Takeaway
- Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a safe and effective first-line treatment option for HIV/hepatitis B virus (HBV) coinfection.
Why this matters
- Approximately 8% of patients with HIV have chronic HBV infection, with HIV/HBV coinfection rates mounting to 25% in areas endemic to both infections.
- Most patients with HIV/HBV coinfection are...
